AMBU-B Ambu A/S

13.05USD88.90 DKK · CPH-0.34%Mkt Cap: 3.40B USDP/E: 36.74

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, includin…

Institutional holders10 on file

Key Statistics

Company
Market Cap3.40B USD
Enterprise Value3.41B USD
Revenue (TTM)949.56M USD
Gross Profit570.82M USD
Net Income (TTM)94.21M USD
Revenue/Share3.59 USD
Last Price13.05 USD
Fiscal Year EndSep 2026
MR QuarterSep 2026
Employees4.7K
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINDK0060946788
Valuation
P/E (Trailing)36.74
P/E (Forward)23.12
PEG2.85
EV/EBITDA23.90
EV/Revenue3.59
P/S3.58
P/B3.71
EPS (TTM)0.36 USD
EPS (Forward)0.56 USD
52W Range
8.25488% of range13.68
52W High13.68 USD
52W Low8.254 USD
Profitability
Gross Margin60.11%
Oper. Margin13.15%
EBITDA Margin15.02%
Profit Margin9.92%
ROE10.27%
ROA7.81%
ROIC10.31%
ROCE12.32%
Growth
Revenue Growth16.00%
Earnings Growth116.70%
Cash Flow & Leverage
Operating CF156.28M USD
CapEx (TTM)84.82M USD
FCF Margin3.84%
FCF Yield1.07%
Net Debt8.36M USD
Net Debt/EBITDA0.06
Net Debt/FCF0.23
Balance Sheet
Debt/Equity0.09
Current Ratio2.35
Quick Ratio1.21
Book Value/Sh3.52 USD
Cash/Share0.30 USD
Dividends
Fwd Div Rate0.08 USD
Trail. Div Rate0.08 USD
Div. Yield0.63%
5Y Avg Yield0.20%
Payout Ratio16.94%
Ex-Div DateDec 3, 2026
Pay Date—
Splits
Last Split5:1
Split DateJan 3, 2018
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)14.33 USD
Upside (mean)+9.9%
Target Range12.47 USD – 16.92 USD
12.47+9.9% to mean16.92
# Analysts8
Ownership
Shares Out.226.12M
Float178.19M
Insiders0.00%
Institutions27.12%
Technical
SMA 5011.15 (+17.0%)
SMA 20010.44 (+24.9%)
Beta1.41
S&P 52W Chg12.00%
Avg Vol (30d)686.68K
Avg Vol (10d)929.71K
Technical Indicators
RSI (14)65.6
MACD3.7824
MACD Signal3.8364
MACD Hist.-0.0539
BB Upper13.78 USD
BB Middle12.50 USD
BB Lower11.23 USD
BB Width20.42%
ATR (14)0.3470 USD
Vol Ratio (20d)0.77x

About Ambu (CPH: AMBU-B)

›

Ambu (CPH: AMBU-B) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 4,664 employees.

The shares were at 88.90 DKK on 19 November 2026, up 8.3% over 52 weeks. Its 52-week range is 56.25 DKK to 93.25 DKK: the price is 4.7% below the high and 58.0% above the low.

At a market capitalisation of 23.15B DKK, it trades at 36.7 times trailing earnings and 23.1 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 43% for AMBU-B. It pays a dividend yielding 0.63% (it pays out 17% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

Ambu reports return on equity of 10.3%, an operating margin of 13.2% and revenue up 16.0% year over year.

Its debt exceeds its cash by 57.00M DKK, a debt-to-equity ratio of 0.09. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 8 analysts cover the stock, with an average rating of Hold; their mean price target of 97.66 DKK is 9.9% above the current price. The next earnings report is expected on 28 January 2027.